Exit Nation: Mitsubishi Tanabe Acquires Israeli Pharma Company NeuroDerm For $1.1B

Japan’s Mitsubishi Tanabe Pharma Corporation (MTPC) is buying Israeli pharmaceutical company NeuroDerm, which is traded on the NASDAQ, for a whopping $1.1 billion (or $39 per share), in one of the largest deals in Israel’s history. Read the Article here By Minna Fingerhood from NoCamels.